DE60006363D1 - Aminoacylaroylpyrrole für die behandlung des neuropathischen schmerzes - Google Patents

Aminoacylaroylpyrrole für die behandlung des neuropathischen schmerzes

Info

Publication number
DE60006363D1
DE60006363D1 DE60006363T DE60006363T DE60006363D1 DE 60006363 D1 DE60006363 D1 DE 60006363D1 DE 60006363 T DE60006363 T DE 60006363T DE 60006363 T DE60006363 T DE 60006363T DE 60006363 D1 DE60006363 D1 DE 60006363D1
Authority
DE
Germany
Prior art keywords
aminoacylaroylpyrrole
neuropathic pain
treating neuropathic
treating
pain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60006363T
Other languages
English (en)
Other versions
DE60006363T2 (de
Inventor
R Carson
M Pitis
E Rogers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Application granted granted Critical
Publication of DE60006363D1 publication Critical patent/DE60006363D1/de
Publication of DE60006363T2 publication Critical patent/DE60006363T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333—Radicals substituted by oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
DE60006363T 1999-02-18 2000-02-17 Aminoacylaroylpyrrole für die behandlung des neuropathischen schmerzes Expired - Lifetime DE60006363T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12047799P 1999-02-18 1999-02-18
US120477P 1999-02-18
PCT/US2000/004063 WO2000048584A2 (en) 1999-02-18 2000-02-17 Aroyl aminoacyl pyrroles for use in the treatment of neuropathic pain

Publications (2)

Publication Number Publication Date
DE60006363D1 true DE60006363D1 (de) 2003-12-11
DE60006363T2 DE60006363T2 (de) 2005-07-21

Family

ID=22390558

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60006363T Expired - Lifetime DE60006363T2 (de) 1999-02-18 2000-02-17 Aminoacylaroylpyrrole für die behandlung des neuropathischen schmerzes

Country Status (14)

Country Link
US (2) US6191142B1 (de)
EP (1) EP1154996B1 (de)
JP (1) JP2002537247A (de)
AR (1) AR022620A1 (de)
AT (1) ATE253556T1 (de)
AU (1) AU3367500A (de)
CA (1) CA2361390A1 (de)
DE (1) DE60006363T2 (de)
DK (1) DK1154996T3 (de)
ES (1) ES2209843T3 (de)
HK (1) HK1041003B (de)
TR (1) TR200103219T2 (de)
TW (1) TW562797B (de)
WO (1) WO2000048584A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6573267B2 (en) 2000-06-30 2003-06-03 Ortho-Mcneil Pharmaceutical, Inc. Useful aroyl aminoacyl pyrrole compounds
CA2432776A1 (en) * 2000-12-20 2002-07-25 Ortho-Mcneil Pharmaceutical, Inc. Isoindolyl and isoquinolinyl aroyl pyrrole compounds
SI1458386T1 (sl) * 2001-12-27 2007-08-31 Ortho Mcneil Pharm Inc Aroil pirol heteroeril in metanoli, uporabni za zdravljenje motnje centralnega živčnega sistema
AU2003207219A1 (en) 2002-02-05 2003-09-02 Ajinomoto Co., Inc. Medicinal compositions containing gabapentin or pregabalin and n-type calcium channel antagonist
HU230403B1 (hu) * 2003-12-19 2016-04-28 Pál Kocsis Nátrium csatorna blokkoló és szerotonin újrafelvétel gátló tartalmú gyógyszerkészítmény
EP2256103A1 (de) 2009-05-07 2010-12-01 Biosynth AG Neue Anzeigerplattform

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5332736A (en) 1993-11-01 1994-07-26 Ortho Pharmaceutical Corporation Anti-convulsant aroyl aminoacylpyrroles
US5418236A (en) 1993-12-23 1995-05-23 Ortho Pharmaceutical Corporation Anxiolytic aroyl piperidinyl and piperazinylacyl pyrroles
JP2001500121A (ja) 1996-08-23 2001-01-09 アルゴス ファーマシューティカル コーポレーション 神経障害性の痛みを治療する組成物を含む抗けいれん剤
US5760007A (en) 1997-07-16 1998-06-02 Ortho Pharmaceutical Corporation Anticonvulsant derivatives useful in treating neuropathic pain

Also Published As

Publication number Publication date
JP2002537247A (ja) 2002-11-05
US6191142B1 (en) 2001-02-20
DE60006363T2 (de) 2005-07-21
ATE253556T1 (de) 2003-11-15
EP1154996B1 (de) 2003-11-05
HK1041003B (zh) 2004-05-07
CA2361390A1 (en) 2000-08-24
AR022620A1 (es) 2002-09-04
US6369228B2 (en) 2002-04-09
US20010044452A1 (en) 2001-11-22
TW562797B (en) 2003-11-21
AU3367500A (en) 2000-09-04
EP1154996A2 (de) 2001-11-21
WO2000048584A3 (en) 2000-12-07
HK1041003A1 (en) 2002-06-28
TR200103219T2 (tr) 2002-04-22
DK1154996T3 (da) 2004-02-16
WO2000048584A2 (en) 2000-08-24
ES2209843T3 (es) 2004-07-01

Similar Documents

Publication Publication Date Title
DE69927823D1 (de) Hydrogel für die therapeutische behandlung von aneurysmas
ATE312117T1 (de) Verbindungen für die behandlung von ischämie
DE69700723T2 (de) Behandlung für Formgedächtnislegierung
DE60130675D1 (de) Selektive agonisten des ep4 rezeptors für die behandlung von osteoporose
ZA200202449B (en) Use of retigabin for treating neuropathic pain.
ATE288431T1 (de) Substituierte bizyklische derivate für die behandlung von unnormalem zellwachstum
DE60218493D1 (de) Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten
ATE345331T1 (de) Verbindungen verwendbar für die behandlung von entzündungskrankheiten
DE60316538D1 (de) Dihydrobenzodiazepin-2-on-derivative für die behandlung von neurologischen erkrankungen
ATE498309T1 (de) Synergistische zusammensetzungen für die behandlung von saatgut
ATE254458T1 (de) Antibiotische zusammensetzungen zur behandlung des auges
FR2814945B1 (fr) Procede de traitement de la canitie
DE60239558D1 (de) Kombinationen für die behandlung von immun-entzündlichen erkrankungen
ATE263777T1 (de) Zusammensetzungen zur behandlung von entzündungsreaktionen
DE60105614D1 (de) Oxazinochinolone für die behandlung viraler infektionen
ATE493125T1 (de) Carbamatverbindungen zur behandlung von schmerz
DE59801385D1 (de) Durchlaufanlage für die behandlung von werkstücken
DE69906856D1 (de) Methode für die Inhibition von Haarwuchs
DE69608864T2 (de) Mittel für die Wasserbehandlung
DE60006363D1 (de) Aminoacylaroylpyrrole für die behandlung des neuropathischen schmerzes
ATE515266T1 (de) 2-(amino-3,4-dioxo-1-cyclobuten-1- yl)aminoalkylsäure-derivate für die schmerzbehandlung
DE69900034D1 (de) System für die Behandlung von Dung
DE59902439D1 (de) Knüpfapparat für Ballenpressen
ATE527999T1 (de) Asimadolin für die behandlung des irritable bowel syndroms
ATE391507T1 (de) S-methyl-dihydro-ziprasidone für die behandlung von schizophrenie

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN